Amosulalol is a pharmaceutical compound primarily classified as a beta-blocker, which is used in the management of hypertension and certain cardiac conditions. It exhibits both beta-adrenergic blocking and alpha-adrenergic blocking properties, making it effective in reducing heart rate and lowering blood pressure. The compound is known for its ability to improve blood flow and reduce peripheral resistance, which contributes to its antihypertensive effects. Amosulalol is typically administered orally and is characterized by its moderate lipophilicity, which influences its absorption and distribution in the body. The substance has a relatively short half-life, necessitating multiple doses throughout the day for sustained therapeutic effects. As with many beta-blockers, potential side effects may include fatigue, dizziness, and bradycardia. Its use should be carefully monitored, especially in patients with respiratory conditions or those on other cardiovascular medications. Overall, amosulalol represents a valuable option in the pharmacological management of cardiovascular diseases.

Amosulalol

85320-68-9: Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-, (±)-, 5-[1-Hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methylbenzenesulfonamide, Amosulalol, Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-

Amosulalol is a combined alpha and beta adrenoceptor antagonist.

Please enquire for more information about Amosulalol including the price, delivery time and more detailed product information at the technical inquiry form on this page

CAS 85320-68-9: Amosulalol

Amosulalol

Ref: TM-T30027

Amosulalol

Ref: 3D-KDA32068

Amosulalol

Ref: 54-BUP03972